Neglected Tropical Diseases: Why Aren't We Doing More?
"A Deep Dive into the Fight Against Poverty-Related Illnesses and What Scientists Can Do."
Imagine a world where simple infections can lead to years of suffering, disability, and even death. This is the reality for the 1.9 billion people affected by Neglected Tropical Diseases (NTDs). These diseases, often overshadowed by higher-profile illnesses like malaria and HIV/AIDS, primarily affect impoverished communities with limited access to clean water, adequate nutrition, and healthcare.
The World Health Organization (WHO) identifies 20 diseases as NTDs, a diverse group of viral, bacterial, and parasitic infections. These illnesses perpetuate a cycle of poverty, hindering economic development and individual potential. While significant medical advancements have been made in recent decades, effective treatments for NTDs remain woefully inadequate.
But there is hope. As highlighted by the German Network against Neglected Tropical Diseases (DNTDs), a growing global effort is underway to combat these diseases. This article delves into the current state of NTD research, the importance of translational research, and how scientists can play a crucial role in achieving "health for all."
A Persistent Global Health Burden
Neglected tropical diseases remain a substantial but often underrecognized global health concern. They can cause illness, disability, and social and economic consequences, particularly in communities facing poverty and limited access to health services. Their effects extend beyond individual health to household productivity and broader development. The scale and distribution of this burden vary across diseases and settings.
Integrated Control and Its Limits
NTDs include illnesses caused by viruses, bacteria, parasites, fungi, and toxins, so control cannot rely on a single method. The WHO coordinates policies and strategies supporting prevention, control, elimination, and eradication interventions, including for some zoonotic diseases. NTDs are preventable and treatable, yet they can still produce severe illness, disability, disfigurement, and early mortality. Emerging environmental DNA and RNA technology is being assessed as a way to improve disease detection and support progress toward the 2030 targets.
A Long-Standing Health Challenge
The history of neglected tropical diseases reflects a long struggle with infections that disproportionately affect tropical and subtropical communities. Scientific advances have improved understanding of their causes, transmission, prevention, and treatment. However, progress has been uneven, and many affected populations continue to face limited attention and resources. The historical record therefore combines important medical milestones with persistent gaps in access and implementation.
The Stark Reality of Neglected Tropical Diseases
NTDs are more than just medical issues; they are significant barriers to global health and economic development. These diseases can keep individuals bedridden for weeks or months, prevent them from working, and cause lifelong disabilities or disfigurement. The impact is especially devastating for children, hindering their growth, development, and educational opportunities.
- Limited Access: NTDs thrive in areas with poor sanitation, limited access to clean water, and inadequate healthcare infrastructure.
- Economic Burden: The diseases reduce productivity, increase healthcare costs, and trap communities in cycles of poverty.
- Social Stigma: Many NTDs cause disfigurement and disability, leading to social stigma and discrimination.
- Lack of Investment: NTDs receive disproportionately less funding compared to other global health challenges, hindering research and development efforts.
Research Still Filling Critical Gaps
Recent research continues to examine how NTDs can be detected, prevented, treated, and ultimately eliminated. Reviews emphasize that these diseases involve diverse pathogens and produce health, social, and economic consequences. Current work also explores improved surveillance and more coordinated strategies. Evidence remains important for determining which approaches can work reliably across different settings.
Why Progress Has Not Been Enough
The persistence of NTDs suggests that treatment alone does not resolve every barrier to control. Programs may struggle when prevention, diagnosis, health-system capacity, and community conditions are not addressed together. Uneven resources and limited attention can weaken otherwise effective interventions. These shortcomings help explain why progress can coexist with continuing disease transmission and suffering.
Disease Burden and Inequality
NTDs are caused by diverse organisms and affect millions of people in tropical and subtropical conditions. They are more prevalent among people living in poverty and lacking access to clean water. Recent sources also describe NTDs as affecting over a billion people and hindering progress in economically disadvantaged areas, particularly in Sub-Saharan Africa. Together, these accounts link disease burden not only to geography but also to socioeconomic inequality.
A Call to Action: How Scientists Can Make a Difference
The fight against NTDs requires a collaborative effort from researchers, policymakers, healthcare professionals, and affected communities. Scientists have a vital role to play in developing new tools and strategies to combat these diseases and improve the lives of millions. By focusing on translational research and fostering collaborations, we can move closer to a world free from the burden of NTDs.
From Treatment to Health Equity
Expert commentary frames NTD control as both a moral imperative and a strategic necessity for global health security and the Sustainable Development Goals. The WHO NTD roadmap for 2021–2030 calls for accountability for impact, integration across diseases, mainstreaming within national health systems, and country ownership. Yet evidence on implementing this shift in resource-limited settings remains limited. Uganda's experience, including annual mass drug administration for schistosomiasis and intestinal worm infections since 2003, illustrates why years of treatment do not by themselves end NTDs.
Building the Next Phase of Control
Future progress will depend on stronger awareness, better identification of previously unknown cases, and sufficient resources for sustained action. The WHO's 2024 report highlights slow post-COVID-19 recovery, funding uncertainties, geopolitical disruptions, climate change, gaps in knowledge and tools, and insufficient data as continuing challenges. The WHO's 2025 report also records a measurable decline in the global NTD burden after 20 years of action and data from the programme established in 2005. These developments suggest that progress is possible, but vulnerable to disruptions and uneven capacity.
Health Beyond the Clinic
NTDs are shaped by broader systems as well as by medical treatment. Poverty, infrastructure gaps, unequal access to care, limited data, and competing priorities can all make sustained control more difficult. Climate and geopolitical disruptions may further complicate prevention and service delivery. Addressing these conditions requires coordination across health systems, communities, governments, and international partners.
Lives Affected by Neglect
For affected people, NTDs can mean prolonged illness, disability, stigma, and reduced opportunities. The consequences may reach household income, children's development, productivity, and maternal well-being. These effects are often concentrated among people with the fewest resources and least access to care. The human cost is therefore central to understanding why greater attention and sustained action are needed.